- Latest available (Revised)
- Point in Time (19/03/2007)
- Original (As adopted by EU)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Version Superseded: 12/08/2008
Point in time view as at 19/03/2007.
There are currently no known outstanding effects for the Commission Decision of 19 March 2007 on a survey for chronic wasting disease in cervids (notified under document number C(2007) 860) (Text with EEA relevance) (2007/182/EC) (repealed).
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies(1), and in particular Article 6(1) thereof,
Whereas:
(1) Chronic wasting disease is a transmissible spongiform encephalopathy (TSE) affecting cervids, which is widespread in North America but which has never been reported to date in the Community.
(2) On 3 June 2004, the European Food Safety Authority (EFSA) published an opinion recommending that a targeted surveillance should be undertaken of cervids in the Community. The aim of such surveillance would be to detect the possible presence of TSEs in cervids. Accordingly, provision should be made for Member States to carry out surveys in line with that opinion.
(3) Regulation (EC) No 999/2001 lays down rules for the prevention, control and eradication of TSEs in animals. That Regulation, as amended by Regulation (EC) No 1923/2006 lays down provision for monitoring programmes for TSEs in cervids. Accordingly, it is now possible to provide for surveys for TSEs in cervids to be carried out by Member States in this Decision.
(4) Those surveys should include wild and farmed deer species. Since wild deer should primarily be sampled during the hunting season which is of limited duration, in order to allow Member States sufficient time to achieve target numbers of samples, this Decision should therefore apply following the adoption of Regulation (EC) No 1923/2006 amending Regulation (EC) No 999/2001.
(5) Member States should submit an annual report of the results of those surveys on cervids. The detection of a positive finding of TSE in cervids must be immediately reported to the Commission.
(6) Member States should ensure that cervids tested for TSEs do not enter the commercial food chain until a negative result has been obtained.
(7) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS DECISION:
This Decision lays down rules for a survey to detect the presence of chronic wasting disease (CWD) in animals of the deer family, namely cervids (the survey).
For the purposes of this Decision the definitions set out in Annex I shall apply.
1.Member States shall carry out a survey to detect the presence of CWD in cervids in accordance with the minimum requirements in Annex II.
2.Member States shall complete their survey no later than the end of the 2007 hunting season.
Member States shall carry out the measures set out in Annex III following testing for CWD.
Member States shall submit to the Commission the following reports:
a report immediately following the discovery of a positive or inconclusive finding for transmissible spongiform encephalopathy in a cervid;
an annual report of the results of surveys as set out in Annex IV.
The Commission shall present to the Member States a summary of the reports provided for in Article 5.
This Decision is addressed to the Member States.
Done at Brussels, 19 March 2007.
For the Commission
Markos Kyprianou
Member of the Commission
For the purposes of this Decision, the following definitions shall apply:
‘target species’ means wild and farmed red deer (Cervus elaphus) and/or wild white-tailed deer (Odocoileus virginianus);
‘target Member States’ means those Member States with sufficient target species populations to allow statistically required sample sizes to be achieved; they differ depending on target species and whether wild or farmed target species and are listed in Tables 1 and 2 in Annex II;
‘clinical/sick cervids’ means cervids showing abnormal behavioural signs and/or locomotor disturbances and/or generally in poor condition;
‘road-injured or killed cervids’ means cervids hit by road vehicles for which the ante-mortem condition cannot be ascertained;
‘fallen/culled cervids’ means cervids found dead on-farm or in the wild and farmed cervids culled for health/age reasons;
‘healthy slaughtered cervids’ means healthy farmed cervids slaughtered in the slaughterhouse or on farm;
‘healthy shot cervids’ means healthy wild cervids shot during the hunting season;
‘target groups’ means the cervids defined at points (c) to (g).
Those samples may be taken from all target groups in the target Member States.
all cervids must be over 18 months of age; the age shall be estimated on the basis of dentition, obvious signs of maturity, or any other reliable information;
in the case of healthy shot cervids, samples must be taken in particular from male cervids;
in the case of healthy slaughtered cervids, samples must be taken in particular from older male and female cervids.
densely populated deer areas;
high scrapie incidence;
high BSE incidence;
cervids which have consumed potentially TSE-contaminated feeding stuffs;
cervids on farms or in regions where imports from regions affected by CWD of cervids or their products have been recorded in the past.
All Member States shall take samples for CWD from clinical/sick cervids and fallen/culled cervids, as a priority, as well as from road-injured or killed cervids of all cervid species. The competent authority of the Member States shall endeavour to maximise awareness of these cervids and to ensure that as many such cervids are tested for CWD as possible.
Wild red deer (Cervus elaphus), and White-tailed deer (Odocoileus virginianus)
Target species population | Sample size | |
---|---|---|
Czech Republic | 25 000 | 598 |
Germany | 150 000 | 598 |
Spain | 220 000 to 290 000 | 598 |
France | 100 000 | 598 |
Italy | 44 000 | 598 |
Latvia | 28 000 | 598 |
Hungary | 74 000 | 598 |
Austria | 150 000 | 598 |
Poland | 600 000 | 598 |
Slovakia | 38 260 | 598 |
Finland | 30 000 | 598 |
United Kingdom | 382 500 | 598 |
Farmed red deer (Cervus elaphus elaphus)
Target species population | Sample size | |
---|---|---|
Czech Republic | ≥ 9 000 | 576 |
Germany | 11 500 | 598 |
France | 17 000 | 598 |
Ireland | 10 000 | 581 |
Austria | 10 000 | 581 |
United Kingdom | 28 000 | 598 |
A sample of obex shall be collected and tested for each cervid in the samples referred to in points 1 and 2 of this Annex. At least a portion of each sample shall be kept fresh or frozen until a negative result is obtained, in case bioassay is required.
The competent authority of the Member States must refer to point 3 of Chapter C of Annex X to Regulation EC (No) 999/2001 for guidance on methods and protocols.
Rapid tests as referred to in point 4 of Chapter C of Annex X to Regulation EC (No) 999/2001 used for transmissible spongiform encephalopathy (TSE) detection in obex of bovine or small ruminant animals shall be considered suitable for use in the sampling referred to in points 1 and 2 of this Annex. Member States may also use immunohistochemistry for screening purposes for which purpose they shall satisfy a proficiency test by the Community Reference Laboratory. Where a Member State is unable to confirm a positive rapid test result, they shall send adequate tissue to the CRL for confirmation. In the case of positive findings of TSE, the protocol as provided for in point 3.2, (c)(i) and (ii), Chapter C of Annex X to Regulation EC (No) 999/2001 shall apply.
The prion protein genotype shall be determined for each positive finding of TSE in cervids in accordance with the guidelines of the Community Reference Laboratory for TSEs.
Information to be presented by Member States in their annual report on the survey results for CWD
The number of cervid samples submitted for testing, by target group according to the following criteria:
species,
farmed or wild cervids,
target group,
sex,
age.
The results of the rapid and confirmatory tests (number of positives and negatives) and, where applicable, of the discriminatory testing, the tissue sampled and the rapid test and confirmatory technique used.
The geographical location, including the country of origin if not the same as the reporting Member State, of positive cases of TSE.
The genotype and species of each cervid found positive for TSE.
The results of the sampling for CWD for the previous year shall be reported in an annual report.
This report shall be submitted as soon as possible, but no later than six months after the end of each year of the survey.
The 2007 report shall include the results of the 2007 hunting season, even when some samples will have been taken in 2008.
OJ L 147, 31.5.2001, p. 1. Regulation as last amended by Regulation (EC) No 1923/2006 (OJ L 404, 30.12.2006, p. 1).
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: